Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184488
Max Phase: Preclinical
Molecular Formula: C58H72F3N9O11S
Molecular Weight: 1160.33
Associated Items:
ID: ALA5184488
Max Phase: Preclinical
Molecular Formula: C58H72F3N9O11S
Molecular Weight: 1160.33
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOCCOCCOCCNC(=O)c2ccc(-c3ccc(N4CCN(C)C(NC(=O)c5c[nH]c(=O)cc5C(F)(F)F)C4)cc3)cc2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C58H72F3N9O11S/c1-37-51(82-36-65-37)41-8-6-38(7-9-41)32-64-55(76)47-30-44(71)34-70(47)56(77)52(57(2,3)4)67-49(72)18-22-78-24-26-80-28-29-81-27-25-79-23-19-62-53(74)42-12-10-39(11-13-42)40-14-16-43(17-15-40)69-21-20-68(5)48(35-69)66-54(75)45-33-63-50(73)31-46(45)58(59,60)61/h6-17,31,33,36,44,47-48,52,71H,18-30,32,34-35H2,1-5H3,(H,62,74)(H,63,73)(H,64,76)(H,66,75)(H,67,72)/t44-,47+,48?,52-/m1/s1
Standard InChI Key: ACMVOJXLOLDHDX-XTVHMVLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1160.33 | Molecular Weight (Monoisotopic): 1159.5024 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dölle A, Adhikari B, Krämer A, Weckesser J, Berner N, Berger LM, Diebold M, Szewczyk MM, Barsyte-Lovejoy D, Arrowsmith CH, Gebel J, Löhr F, Dötsch V, Eilers M, Heinzlmeir S, Kuster B, Sotriffer C, Wolf E, Knapp S.. (2021) Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders., 64 (15.0): [PMID:33980013] [10.1021/acs.jmedchem.1c00146] |
Source(1):